FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014524975> ?p ?o ?g. }

• W2014524975 endingPage "250" @default.
• W2014524975 startingPage "243" @default.
• W2014524975 abstract "<i>Objective:</i> Alterations in the transforming growth factor-β (TGF-β) signaling cascade are engaged in the development of human neoplasms through the deregulation of proliferation, differentiation and migration. However, in endometrial cancer, the role of endoglin, which acts as an accessory receptor in the TGF-β pathway, is still unknown. The aim of our study was the evaluation of endoglin mRNA and protein expression levels in endometrial cancer as compared to normal endometrium. TGF-β₁ and TGF-β type II receptor were involved in the investigation since they directly cooperate with endoglin during signal propagation. Obtained results were correlated with clinicopathological parameters of studied material to determine endoglin contribution to tumor development and progression. <i>Methods:</i> mRNA level assessment was performed using real-time technique, whereas protein expression was determined by ELISA assay. <i>Results:</i> The endoglin mRNA level was not significantly altered in cancerous samples as compared to normal tissue, whereas its protein level demonstrated significant upregulation (p < 0.001) associated with increased tumor malignancy, assessed by histological grade and myometrium infiltration. <i>Conclusions:</i> An increase in endoglin protein expression level may interfere with the oncogenic potential of TGF-β₁ and TGF-β type II receptor in endometrial cancer. Correlation of the endoglin level with pronounced cancer malignancy suggests that it may be regarded as a potential prognostic marker of primary endometrial cancer." @default.
• W2014524975 created "2016-06-24" @default.
• W2014524975 creator A5004741172 @default.
• W2014524975 creator A5015594819 @default.
• W2014524975 creator A5040562863 @default.
• W2014524975 creator A5052006733 @default.
• W2014524975 creator A5054796107 @default.
• W2014524975 creator A5064978476 @default.
• W2014524975 creator A5075326917 @default.
• W2014524975 date "2011-01-01" @default.
• W2014524975 modified "2023-09-25" @default.
• W2014524975 title "Expression of Endoglin in Primary Endometrial Cancer" @default.
• W2014524975 cites W140268124 @default.
• W2014524975 cites W1565561072 @default.
• W2014524975 cites W1760215417 @default.
• W2014524975 cites W1802329741 @default.
• W2014524975 cites W1964118422 @default.
• W2014524975 cites W1966223430 @default.
• W2014524975 cites W1973515006 @default.
• W2014524975 cites W1978146894 @default.
• W2014524975 cites W1981504612 @default.
• W2014524975 cites W1991691622 @default.
• W2014524975 cites W1996141843 @default.
• W2014524975 cites W1996427377 @default.
• W2014524975 cites W1997576290 @default.
• W2014524975 cites W1999132074 @default.
• W2014524975 cites W1999332302 @default.
• W2014524975 cites W2001487535 @default.
• W2014524975 cites W2002449187 @default.
• W2014524975 cites W2003608352 @default.
• W2014524975 cites W2008336631 @default.
• W2014524975 cites W2009629707 @default.
• W2014524975 cites W2010257968 @default.
• W2014524975 cites W2013958991 @default.
• W2014524975 cites W2018759355 @default.
• W2014524975 cites W2018867485 @default.
• W2014524975 cites W2019453487 @default.
• W2014524975 cites W2022211980 @default.
• W2014524975 cites W2028572689 @default.
• W2014524975 cites W2030662016 @default.
• W2014524975 cites W2031222466 @default.
• W2014524975 cites W2033545943 @default.
• W2014524975 cites W2033806856 @default.
• W2014524975 cites W2034400342 @default.
• W2014524975 cites W2035653659 @default.
• W2014524975 cites W2038468525 @default.
• W2014524975 cites W2044466245 @default.
• W2014524975 cites W2044988711 @default.
• W2014524975 cites W2053182913 @default.
• W2014524975 cites W2053312952 @default.
• W2014524975 cites W2053869888 @default.
• W2014524975 cites W2054713383 @default.
• W2014524975 cites W2054975498 @default.
• W2014524975 cites W2057531505 @default.
• W2014524975 cites W2067777254 @default.
• W2014524975 cites W2075704804 @default.
• W2014524975 cites W2080558583 @default.
• W2014524975 cites W2084954119 @default.
• W2014524975 cites W2092873962 @default.
• W2014524975 cites W2095025412 @default.
• W2014524975 cites W2100446922 @default.
• W2014524975 cites W2100825082 @default.
• W2014524975 cites W2104029845 @default.
• W2014524975 cites W2105632053 @default.
• W2014524975 cites W2106441070 @default.
• W2014524975 cites W2110167662 @default.
• W2014524975 cites W2111331823 @default.
• W2014524975 cites W2114647260 @default.
• W2014524975 cites W2116510625 @default.
• W2014524975 cites W2119644672 @default.
• W2014524975 cites W2122846135 @default.
• W2014524975 cites W2128462536 @default.
• W2014524975 cites W2130108353 @default.
• W2014524975 cites W2131195370 @default.
• W2014524975 cites W2132860482 @default.
• W2014524975 cites W2135682204 @default.
• W2014524975 cites W2135924006 @default.
• W2014524975 cites W2136280424 @default.
• W2014524975 cites W2137940909 @default.
• W2014524975 cites W2146678830 @default.
• W2014524975 cites W2147754310 @default.
• W2014524975 cites W2153561835 @default.
• W2014524975 cites W2154601080 @default.
• W2014524975 cites W2155544045 @default.
• W2014524975 cites W2158075507 @default.
• W2014524975 cites W2169576730 @default.
• W2014524975 cites W2262976102 @default.
• W2014524975 cites W228720133 @default.
• W2014524975 cites W2306749020 @default.
• W2014524975 cites W2332375831 @default.
• W2014524975 doi "https://doi.org/10.1159/000334240" @default.
• W2014524975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22116456" @default.
• W2014524975 hasPublicationYear "2011" @default.
• W2014524975 type Work @default.
• W2014524975 sameAs 2014524975 @default.
• W2014524975 citedByCount "10" @default.
• W2014524975 countsByYear W20145249752013 @default.
• W2014524975 countsByYear W20145249752014 @default.

• next